SEC Form 4 · accession 0001127602-16-066219
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Jonas
Officer — EVP Legal Affairs,Gen. Counsel
Period of report
Nov 3, 2016
Accepted (ET)
Nov 7, 2016 · 1:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2016 | M | 2,000 | $19.26 | A | 20,120 | D | |
| Common Stock | Nov 3, 2016 | F | 1,360 | $39.18 | D | 18,760 | D | |
| Common Stock | Nov 3, 2016 | M | 4,000 | $27.63 | A | 22,760 | D | |
| Common Stock | Nov 3, 2016 | F | 3,257 | $39.18 | D | 19,503 | D | |
| Common Stock | Nov 3, 2016 | M | 4,000 | $26.09 | A | 23,503 | D | |
| Common Stock | Nov 3, 2016 | F | 3,158 | $39.18 | D | 20,345 | D | |
| Common StockF1 | Nov 7, 2016 | S | 2,555 | $40.40 | D | 17,790 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sars (Stock Appreciation Rights)F2 | $19.26 | Nov 3, 2016 | M | 2,000 | D | — | Jun 1, 2020 | Common Stock | 2,000 | 0 | D |
| Sars (Stock Appreciation Rights)F2 | $27.63 | Nov 3, 2016 | M | 4,000 | D | — | Jun 1, 2021 | Common Stock | 4,000 | 0 | D |
| Sars (Stock Appreciation Rights)F2 | $26.09 | Nov 3, 2016 | M | 4,000 | D | — | Jun 1, 2022 | Common Stock | 4,000 | 2,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.32 to $40.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- F2The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.